Dr. Andrew S Riemer, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5959 Lawndale St, Ludington, MI 49431 Phone: 231-845-6261 Fax: 231-843-9171 |
Brandon Riemer, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5959 Lawndale St, Ludington, MI 49431 Phone: 231-845-6261 Fax: 231-843-9171 |
Deborah R Wu, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5959 Lawndale St, Ludington, MI 49431 Phone: 231-845-6261 |
News Archive
The American Urological Association (AUA) is pleased to announce the release of a new Guideline for the Management of Ureteral Calculi prepared as a collaborative effort with the European Association of Urology (EAU).
A gene variant that lowers white blood cell levels and is common in individuals with African ancestry contributes to unnecessary bone marrow biopsies, according to a study published June 28 in JAMA Internal Medicine.
Researchers at NYU Langone Medical Center have created stem cells from the eggs of aging mice that could be used for reproductive purposes and regenerative medicine. The study, published in April issue of Aging Cell, found that even though the eggs from older females were slightly less efficient at making stem cells than those from younger females, the capacity to create stem cells was sustained.
Healthcare workers - particularly nurses, nurses' aides, orderlies, and attendants - suffer more musculoskeletal injuries than those working in any other field, a Public Citizen report found. Those injuries cost the U.S. about $7 billion each year, according to the Public Citizen report, which was written by Keith Wrightson and Taylor Lincoln, both of the organization's Congress Watch division. The increased number of on-the-job injuries may be the result of comparatively sparse rates of safety inspections at healthcare facilities, according to 2010 data from the Occupational Safety and Health Administration (Petrochko, 7/19).
TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, announced the presentation of results demonstrating the synergistic antibacterial activity of its lead clinical candidate, TXA709, when combined with cefdinir, a third-generation cephalosporin antibiotic.
› Verified 7 days ago